Want to take quizzes and track your credits?
Until now, most people feared a diagnosis with the dreaded “C word”—cancer—owing to its associated physical, emotional, and financial hardships as well as its social stigma. However, the rapid progression of coronavirus disease 2019 (COVID-19) from a local issue to a global pandemic has quickly made it a competitor for the spot of the most feared disease, and rightly so, given the intense strain it is placing on us individually and as a society at every level. For me, having been diagnosed with both diseases 4 years apart, COVID-19 has brought back memories of being confronted with my own mortality.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Urvi A. Shah, MD, Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 East 74th Street, New York, NY, 10021 (firstname.lastname@example.org).
Published Online: May 7, 2020. doi:10.1001/jamaoncol.2020.1848
Conflict of Interest Disclosures: Dr Shah reported grants from Celgene and the Parker Institute of Cancer Immunotherapy and personal fees from the Physicians Education Resource.
You currently have no searches saved.